SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001070698-11-000143
Filing Date
2011-11-14
Accepted
2011-11-14 06:26:13
Documents
7
Period of Report
2011-08-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR 10-K 083111 raptor10k083111.htm 10-K 2522460
2 REICHENBERGER OFFER LETTER exhibit1017offer.htm EX-10.17 23090
3 POWELL OFFER LETTER exhibit1018offer.htm EX-10.18 23936
4 AUDITOR CONSENT 111411 exhibit231consent.htm EX-23.1 4049
5 CEO CERTIFICATION 111411 exhibit311cert.htm EX-31.1 8853
6 CFO CERTIFICATION 111411 exhibit312cert.htm EX-31.2 9003
7 CEO/CFO CERTIFICATION 111411 exhibit321cert.htm EX-32.1 9164
  Complete submission text file 0001070698-11-000143.txt   2601867
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-25571 | Film No.: 111197448
SIC: 2834 Pharmaceutical Preparations